Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...

Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

The clearance adds another feature for Ceribell to leverage as it tries to persuade hospitals to switch from conventional EEG ...

Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders ...